Business Context and Reporting Period
Company: Perspective Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 08, 2026
Event: Update to corporate presentation (Item 8.01 Other Events).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to announce the update of a corporate presentation and does not contain financial statements or specific financial data points.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this filing. The only reported event is the release of an updated corporate presentation.
Guidance, Outlook, and Risks
Management Commentary: The company updated its corporate presentation, which is filed as Exhibit 99.1. Specific details regarding guidance, outlook, or risks contained within that presentation are not summarized in the text of this 8-K.
Risks and Contingencies: No specific risks or contingencies are detailed in the body of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Corporate Presentation) for updated strategic outlook and operational milestones.
- Verify the trading symbol (CATX) on NYSE American LLC.
- Confirm the date of the presentation update (September 08, 2026) against other recent disclosures.
- Note that this filing contains no audited financial data; refer to the most recent 10-K or 10-Q for financial metrics.